Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Endocrinology and Diabetes


This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.

Recent research outputs

Jakubowicz, D., Wainstein, J., Landau, Z., Bo Ahren, Barnea, M., Bar-Dayan, Y. & Froy, O. 2017 Nov 1 In : Journal of Nutritional Biochemistry. 49, p. 1-7 7 p.

Research output: Contribution to journalArticle

Home, P. D., Bo Ahrén, Reusch, J. E. B., Rendell, M., Weissman, P. N., Cirkel, D. T., Miller, D., Ambery, P., Carr, M. C. & Nauck, M. A. 2017 Sep 1 In : Diabetes Research and Clinical Practice. 131, p. 49-60 12 p.

Research output: Contribution to journalArticle

View All (27)